Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79915.510.0938%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

HealthEquity Inc

HQYNASDAQ
Trade with Public
Trade with Public
$96.07
-2.71-2.74%
At close: Sep 4, 5:00 PM EST
$96.07
N/A
After Hours: Sep 4, 6:32 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

HealthEquity Analyst Price Targets

Wall Street analyst price targets and consensus rating for HealthEquity (HQY).

Price Target Range — 13 Quarters

Analyst Consensus — 17 Analysts

3S.Buy
13Buy
1Sell
Consensus RatingOutperform# Analysts17Avg. Consensus PT$116Upside to Avg. PT+20.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 31, 2026Deutsche BankGeorge HillPT RaiseBuy$135→$142
Aug 28, 2026BTIGDavid LarsenMaintainedBuy$115
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $142

Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $135 to $142.
Benzinga Newsdesk

PRO
BTIG Reiterates Buy on HealthEquity, Maintains $115 Price Target

BTIG analyst David Larsen reiterates HealthEquity (NASDAQ:HQY) with a Buy and maintains $115 price target.
Benzinga Newsdesk

PRO
BTIG Maintains Buy on HealthEquity, Raises Price Target to $115

BTIG analyst David Larsen maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $110 to $115.
Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on HealthEquity, Maintains $108 Price Target

RBC Capital analyst Ryan Halsted reiterates HealthEquity (NASDAQ:HQY) with a Outperform and maintains $108 price target.
Benzinga Newsdesk

PRO
Citizens Maintains Market Outperform on HealthEquity, Raises Price Target to $111

Citizens analyst Constantine Davides maintains HealthEquity (NASDAQ:HQY) with a Market Outperform and raises the price target from $110 to $111.
Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on HealthEquity, Raises Price Target to $108

RBC Capital analyst Ryan Halsted maintains HealthEquity (NASDAQ:HQY) with a Outperform and raises the price target from $100 to $108.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved